Status:
COMPLETED
The Relaxation and Blood Pressure in Pregnancy (REBIP) Study
Lead Sponsor:
University of Toronto
Collaborating Sponsors:
Dalhousie University
AWHONN Canada, with Canadian Nurses Foundation Nursing Care Partnership
Conditions:
Hypertension
Hypertension, Pregnancy-Induced
Eligibility:
FEMALE
Phase:
NA
Brief Summary
Over 10% of women have high blood pressure during their pregnancy which may affect their health or that of their baby. There are currently no methods to prevent most high blood pressure in pregnancy a...
Eligibility Criteria
Inclusion
- Pregnant, and less than or equal to (\<) 36 weeks, 6 days gestation
- At least two prenatal blood pressure readings \> 90 mmHg diastolic
- Has had clinical investigation of the hypertension
- Hearing acuity adequate to hear verbal and audiotaped instructions
- Planning to give birth at one of the study site health centres
- Competent to give informed consent
Exclusion
- Likely to deliver within 10 days (including women with diastolic BP \>110 mmHg, or systolic BP \>170 mmHg; unstable diabetes, concurrent antepartum hemorrhage, preterm labour, and/or other significant medical)
- Prescribed antihypertensive medication at baseline
- Documented psychotic illness
- Unable to understand and read English
Key Trial Info
Start Date :
August 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2007
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT00303173
Start Date
August 1 2004
End Date
February 1 2007
Last Update
June 25 2008
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Womens Health Centre, Eastern Health
St. John's, Newfoundland and Labrador, Canada, A1B 3V6
2
IWK Health Centre
Halifax, Nova Scotia, Canada, B3K 6R8